Glen Eagle Advisors’s GE HealthCare GEHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$19.9K Hold
279
﹤0.01% 567
2025
Q4
$22.9K Sell
279
-21
-7% -$1.64K ﹤0.01% 560
2025
Q3
$22.5K Buy
300
+21
+8% +$1.57K ﹤0.01% 560
2025
Q2
$20.7K Sell
279
-4
-1% -$278 ﹤0.01% 546
2025
Q1
$22.8K Hold
283
﹤0.01% 532
2024
Q4
$22.1K Hold
283
﹤0.01% 539
2024
Q3
$26.6K Hold
283
﹤0.01% 526
2024
Q2
$22.1K Buy
283
+36
+15% +$2.94K ﹤0.01% 533
2024
Q1
$22.5K Sell
247
-14
-5% -$1.17K ﹤0.01% 528
2023
Q4
$20.2K Buy
261
+2
+0.8% +$140 ﹤0.01% 531
2023
Q3
$17.6K Hold
259
﹤0.01% 542
2023
Q2
$21K Buy
259
+25
+11% +$2K ﹤0.01% 524
2023
Q1
$19.2K Buy
+234
New +$16.7K ﹤0.01% 522

Other funds holding GEHC

Glen Eagle Advisors's GEHC Position: Q1 2026 in Review

Glen Eagle Advisors held its GE HealthCare (GEHC) position steady in Q1 2026 at 279 shares worth $19.9K. The position accounts for ﹤0.01% of the portfolio, ranked #567.

Glen Eagle Advisors first reported a position in GEHC in Q1 2023 and has held it in 13 quarters since. The position peaked at $26.6K in Q3 2024. 1,263 funds tracked by Wall St. Rank hold GEHC as of Q1 2026.

  • Glen Eagle Advisors held 279 shares of GE HealthCare worth $19.9K as of Q1 2026.
  • Glen Eagle Advisors left its GE HealthCare share count unchanged in Q1 2026.
  • GE HealthCare made up ﹤0.01% of Glen Eagle Advisors's portfolio in Q1 2026, its #567 holding.
  • Glen Eagle Advisors first reported a position in GE HealthCare in Q1 2023 and has held it in 13 quarters since.
  • Glen Eagle Advisors's GE HealthCare position peaked at $26.6K in Q3 2024.
  • 1,263 funds tracked by Wall St. Rank held GE HealthCare as of Q1 2026.

Based on Glen Eagle Advisors's 13F filing for Q1 2026, filed 15 May 2026.